To report a case of conjunctival pyogenic granuloma after intravitreal injection of anti–vascular endothelial growth factor, bevacizumab.Methods:
A 52-year-old patient after 3 intravitreal bevacizumab injections was found to have a vascular conjunctival nodule at the injection site. A pathologic analysis of the vascular conjunctival nodule was performed after surgical excision.Results:
The pathologic analysis revealed a conjunctival pyogenic granuloma.Conclusion:
Conjunctival pyogenic granuloma can complicate an otherwise uneventful intravitreal anti–vascular endothelial growth factor injection.